| 135 |
functional change |
|
eggshell
(UBERON:0005079)
|
119: N/A, Gap
|
| 134 |
decreased |
|
eggshell
(UBERON:0005079)
|
106: Reduction, Eggshell thickness
|
| 133 |
decreased |
bicarbonate transport
(GO:0015701)
|
hydrogencarbonate
(CHEBI:17544)
|
49: Reduction, Ca and HCO3 transport to shell gland
|
| 132 |
decreased |
|
prostaglandin E2
(CHEBI:15551)
|
2 Events
|
| 131 |
decreased |
prostaglandin-endoperoxide synthase activity
(GO:0004666)
|
prostaglandin G/H synthase 2
(PR:000013428)
|
79: Inhibition, Cyclooxygenase activity
|
| 130 |
decreased |
prostaglandin-endoperoxide synthase activity
(GO:0004666)
|
prostaglandin G/H synthase 1
(PR:000013427)
|
2 Events
|
| 129 |
occurrence |
|
cholestasis
(MESH:D002779)
|
2 Events
|
| 128 |
increased |
inflammatory response
(GO:0006954)
|
|
5 Events
|
| 127 |
increased |
cytokine secretion
(GO:0050663)
|
Cytokine
(FMA:84050)
|
87: Release, Cytokine
|
| 126 |
increased |
|
bile
(UBERON:0001970)
|
214: Bile accumulation, Pathological condition
|
| 125 |
increased |
gene expression
(GO:0010467)
|
bile acid receptor
(PR:000011396)
|
288: Activation of specific nuclear receptors, Transcriptional change
|
| 124 |
decreased |
transport
(GO:0006810)
|
bile salt export pump
(PR:000003549)
|
41: Inhibition, Bile Salt Export Pump (ABCB11)
|
| 123 |
increased |
oxidative stress
(MP:0003674)
|
|
3 Events
|
| 122 |
decreased |
long-term synaptic potentiation
(GO:0060291)
|
|
166: Decreased, Long-term potentiation (LTP)
|
| 121 |
decreased |
|
nitric oxide
(CHEBI:16480)
|
193: Decreased, Nitric Oxide
|
| 120 |
increased |
reactive oxygen species biosynthetic process
(GO:1903409)
|
reactive oxygen species
(CHEBI:26523)
|
1115: Increase, Reactive oxygen species
|
| 119 |
decreased |
ATP biosynthetic process
(GO:0006754)
|
ATP
(CHEBI:15422)
|
4 Events
|
| 118 |
disrupted |
|
mitochondrial respiratory chain
(GO:0005746)
|
178: Mitochondrial electron transport chain, disrupted
|
| 117 |
increased |
|
calcium ion
(CHEBI:39124)
|
50: Increase, Ca++ (intracellular)
|
| 116 |
decreased |
calcium-transporting ATPase activity
(GO:0005388)
|
calcium ion-transporting ATPase complex
(GO:0090534)
|
51: Inhibition, Ca++ ATPase
|
| 115 |
decreased |
|
Follicle stimulating hormone
(CHEBI:81569)
|
129: Reduction, Gonadotropins, circulating concentrations
|
| 114 |
decreased |
|
Luteinizing hormone
(CHEBI:81568)
|
2 Events
|
| 113 |
decreased |
oocyte development
(GO:0048599)
|
|
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development
|
| 112 |
decreased |
oocyte growth
(GO:0001555)
|
|
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development
|
| 111 |
decreased |
receptor-mediated endocytosis
(GO:0006898)
|
vitellogenins
(MESH:D014819)
|
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development
|